BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 53 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $348,000 | +47.5% | 17,500 | -4.0% | 0.02% | +16.7% |
| Q2 2016 | $236,000 | -16.0% | 18,225 | -39.2% | 0.02% | +50.0% |
| Q1 2016 | $281,000 | -45.6% | 30,000 | +17.6% | 0.01% | -66.7% |
| Q4 2015 | $517,000 | +73.5% | 25,500 | +24.4% | 0.04% | +176.9% |
| Q3 2015 | $298,000 | -74.3% | 20,500 | -59.0% | 0.01% | -74.5% |
| Q1 2015 | $1,159,000 | +0.6% | 50,000 | 0.0% | 0.05% | +27.5% |
| Q4 2014 | $1,152,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $1,356,000 | 0.23% |
| X-Square Capital, LLC | 199,791 | $258,000 | 0.15% |
| Nikko Asset Management Americas, Inc. | 2,300,682 | $2,968,000 | 0.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $516,000 | 0.04% |
| Baker Brothers Advisors | 2,677,818 | $3,454,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 129,417 | $167,000 | 0.02% |
| ARK Investment Management | 417,433 | $538,000 | 0.01% |
| ALGERT GLOBAL LLC | 36,806 | $47,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 352,465 | $455,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 66,472 | $86,000 | 0.01% |